Inland Empire Weekly |
Still an Original
Inland Empire Weekly Rodriguez, who recently called attention to kidney transplantation with the 2012 award-winning web series Fixing Paco, might use comedy to help a cause, but he avoids getting political in his comic routines. “I am not a preachy guy [on stage],” he adds. |
Heart diseases increasing in India – Times of India
|
Heart diseases increasing in India
Times of India BANGALORE: Over 80 per cent of the deaths in the country are caused due to heart diseases and 50 per cent of the people, who get heart attack die as they couldn’t reach the hospital within an hour, said Dr Vivek Jawali, chief cardiothoracic surgeon of … |
NHS sued after young mother dies from undiagnosed brain tumour – Express.co.uk
|
NHS sued after young mother dies from undiagnosed brain tumour
Express.co.uk A CT scan carried out after brain death revealed a very large brain stem tumour on the right side. Lesley said: “I honestly didn’t know what was the matter, but everyone seemed convinced she was just having a bad pregnancy. “It didn’t have to kill her. |
Chimerix steps toward safer stem-cell transplants with Phase 2 results – Triangle Business Journal
Chimerix steps toward safer stem-cell transplants with Phase 2 resultsTriangle Business JournalThis particular study is unique in that patients were infected with the disease, an often fatal infection in pediatric and adult patients whose immune system…
Gilead leaps ahead with FDA app for PI3K cancer killer – FierceBiotech
|
Gilead leaps ahead with FDA app for PI3K cancer killer
FierceBiotech As the biotech giant had said was a possibility, Gilead is seeking an early approval for idelalisib to combat indolent cases of non-Hodgkin’s lymphoma (NHL) that fail to respond to rituximab and alkylating-agent chemotherapies. Foster City, CA-based … Gilead Seeks FDA Approval for IdelalisibYahoo! News Idelalisib NDA Submitted for Indolent Non-Hodgkin’s LymphomaMonthly Prescribing Reference Gilead Submits NDA for IdelalisibDrug Discovery & Development PharmaTimes all 8 news articles » |
First-Line Standard for Metastatic RCC Upheld – OncLive
OncLiveFirst-Line Standard for Metastatic RCC UpheldOncLiveRobert J. Motzer, MD. The standard of care for metastatic renal cell carcinoma (RCC) prevailed in a randomized comparison of everolimus (Afinitor) and sunitinib (Sutent) as first-line therapy, …
'New pacemaker system offers more options for patients with heart failure' – Times of India
|
‘New pacemaker system offers more options for patients with heart failure‘
Times of India Explaining how quadripolar technology works, Dr Anil Saxena of New Delhi-based Fortis Escorts Hospital says, “Historically, pacing systems that treat heart failure included a lead with only one electrode in the heart. Later, these were replaced by … US firm brings next generation pacemaker in IndiaPress Trust of India |
Inhaled corticosteroids increase pneumonia risk in asthma – medwireNews
Inhaled corticosteroids increase pneumonia risk in asthmamedwireNewsmedwireNews: Research from the UK indicates that the use of inhaled corticosteroids is independently associated with an increased risk for pneumonia and lower respiratory tract infecti…
PharmaPoint: Non-Small Cell Lung Cancer – India Drug Forecast and Market … – Sacramento Bee
PharmaPoint: Non-Small Cell Lung Cancer – India Drug Forecast and Market …Sacramento BeeSummary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradig…
Pluristem Therapeutics Inc. (PSTI): Celgene's And Osiris' IP Positions … – Seeking Alpha
|
Pluristem Therapeutics Inc. (PSTI): Celgene’s And Osiris’ IP Positions …
Seeking Alpha As testimony to stem cell research and development achieving greater status, Novartis AG (NVS) just announced a licensing arrangement with privately-held Regenerex for access to its technology for kidney transplantation to augment in-house cell therapy … |